Synthesis of oligonucleotide inhibitors of DNA (Cytosine-C5) methyltransferase containing 5-azacytosine residues at specific sites

Antisense and Nucleic Acid Drug Development

Volumn 11, Issue 6, 2001, Pages 369-378

  Güimil García, Ramon ^a   Brank, Adam S ^b   Christman, Judith K ^b,c   Marquez, Victor E ^d   Eritja, Ramon ^a,e  

^a EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e INSTITUT DE BIOLOGIA MOLECULAR DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

4 NITROPHENOL; 5 AZA 2' DEOXYCYTIDINE; CARBONYL DERIVATIVE; CYTOSINE DERIVATIVE; DNA; DNA METHYLTRANSFERASE; METHYLTRANSFERASE INHIBITOR; OLIGODEOXYRIBONUCLEOTIDE; OLIGONUCLEOTIDE;

ARTICLE; DRUG SYNTHESIS; ENZYME INHIBITION; METHYLATION; NUCLEOTIDE METABOLISM; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

EID: 0035694834     PISSN: 10872906     EISSN: None     Source Type: Journal    
DOI: 10.1089/108729001753411335     Document Type: Article

References (33)

1. Oxalyl-CPG: A labile support for the synthesis of sensitive oligonucleotide derivatives
2. Solid-phase synthesis of oligodeoxyribonucleotides by the phosphite-triester
3. Use of NPe-protecting groups for the preparation of oligonucleotides without using nucleophiles during the final deprotection
4. A comparative study of supports for the synthesis of oligonucleotides without using ammonia
5. Preparation and properties of oligodeoxynucleotides containing 4-O-butylthymine, 2-fluorohypoxanthine and 5-azacytosine
6. Isolation, characterization, and properties of a labile hydrolysis product of the antitumor nucleoside 5-azacytidine
7. Inhibition of DNA methylation by 5-aza-2′-deoxycytidine suppresses the growth of tumor cell lines
8. DNA methylation in Friend erythroleukemia cells: The effects of chemically induced differentiation and of treatment with inhibitors of DNA methylation
9. Formation of a highly stable complexes between 5-azacytosine-substituted DNA and specific non-histone nuclear proteins. Implications for 5-azacytidine-mediated effects on DNA methylation and gene expression
10. Inhibition of DNA methyltransferase and induction of Friend erythroleukemia cell differentiation by 5-azacytidine and 5-aza-2′-deoxycytidine
11. Synthesis of oligodeoxynucleotides containing 2-substituted guanine derivatives using 2-fluoro-2′-deoxyinosine as common nucleoside precursor
12. Synthesis and properties of oligonucleotides containing 5-aza-2′-deoxycytidine
13. A synthetic procedure for the preparation of oligonucleotides without using ammonia and its application for the synthesis of oligonucleotides containing O-4-alkyl thymidines
14. Preparation of oligonucleotides containing 5-bromouracil and 5-methylcytidine
15. Synthesis of 2′-deoxy-5,6-dihydro-5-azactyosine. Its potential application in the synthesis of DNA containing dihydro-5-aza and 5-azacytosine bases
16. Synthesis of 2′-deoxy-5,6-dihydro-5-azacytosine and 5-azacytosine at specific CpG sites
17. Mitoxantrone and 5-azacytidine for refractory/relapsed anII or cmI in blast crisis: A leukemia intergroup study
18. Cleavage of oligonucleotides from solid-phase supports using o-nitrobenzyl photochemistry
19. The p-nitrophenylethyl (NPE) group. A versatile new blocking group for phosphate and aglycone protection in nucleosides and nucleotides
20. High-performance liquid chromatographic analysis of chemical stability of 5-aza-2′-deoxycytidine
21. Oligonucleotides containing 5,6-dihydro-5-azacytosine at CpG sites can produce potent inhibition of DNA cytosine-C5-methyltransferase without covalently binding to the enzyme
22. Pharmacological approach for optimization of the dose schedule of 5-aza-2′-deoxycytidine (decitabine) for the therapy of leukemia
23. 5-Aza-2′-deoxycytidine (decitabine) and 5-azacytidine in the treatment of acute myeloid leukemias and myelodysplastic syndromes: Past, present and future trends
24. 4-Amino-1-β-D-ribofuranosyl-striazin-2(1H)-one (5-azacytidine)
25. Hydroquinone-O,O′-diacetic acid ("Q-linker") as a replacement for succinyl and oxalyl linker arms in solid phase oligonucleotide synthesis
26. Fetal hemoglobin levels in adults
27. Tris(dimethylamino)sulfonium difluorotrimethylsilicate, a mild reagent for the removal of silicon protecting groups
28. Nucleosides Part LI. The 2-(4-nitrophenyl)ethoxycarbonyl (npeoc) and 2-(2,4-dinitrophenyl)ethoxycarbonyl (dnpeoc) groups for the protection of hydroxy functions in ribonucleosides and 2′-deoxyribonucleosides
29. Mechanism of inhibition of DNA (Cytosine-C5)-methyltransferases by oligodeoxyribonucleotides containing 5,6-dihydro-5-azacytosine
30. Transient protection: Efficient one-flask syntheses of protected deoxynucleotides
31. Lipophilic pro-oligonucleotides are rapidly and efficiently internalized in HeLa cells